Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 May;34(5):875–880. doi: 10.1128/aac.34.5.875

Enzyme immunoconjugates utilizing glucose oxidase and myeloperoxidase are cytotoxic to Candida tropicalis.

D Casentini-Borocz 1, T Bringman 1
PMCID: PMC171709  PMID: 2163245

Abstract

A dual-enzyme immunoconjugate system was evaluated for its cytotoxic effect on Candida tropicalis. Glucose oxidase, which generates hydrogen peroxide in the presence of glucose and oxygen and myeloperoxidase, which catalyzes the oxidation of halides in the presence of hydrogen peroxide, were each conjugated to a C. tropicalis-specific monoclonal antibody. Neither the glucose oxidase nor the myeloperoxidase conjugates exhibited any significant cytotoxic effect by themselves. A combination of glucose oxidase conjugate (3.2 ng/ml) and myeloperoxidase conjugate (12.8 ng/ml) in the presence of 5 mg of glucose per ml, 150 mM chloride, and 50 microM iodide was cytotoxic to C. tropicalis, killing 99.9% of the treated sample. Flow cytometry was used to characterize the binding of the conjugates to yeast cells and demonstrated that the binding of both conjugates to the yeast cell surface is required for cytotoxicity. In addition, the concentrations of conjugates required for a cytotoxic effect were below the concentrations required to saturate all of the yeast cell surface antibody-binding sites.

Full text

PDF
876

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baehner R. L., Karnovsky M. J., Karnovsky M. L. Degranulation of leukocytes in chronic granulomatous disease. J Clin Invest. 1969 Jan;48(1):187–192. doi: 10.1172/JCI105967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bodey G. P. Infectious complications in the cancer patient. Curr Probl Cancer. 1977 Jun;1(12):1–63. doi: 10.1016/s0147-0272(77)80007-x. [DOI] [PubMed] [Google Scholar]
  3. Bringman T. S., Aggarwal B. B. Monoclonal antibodies to human tumor necrosis factors alpha and beta: application for affinity purification, immunoassays, and as structural probes. Hybridoma. 1987 Oct;6(5):489–507. doi: 10.1089/hyb.1987.6.489. [DOI] [PubMed] [Google Scholar]
  4. Bringman T. S., Lindquist P. B., Derynck R. Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell. 1987 Feb 13;48(3):429–440. doi: 10.1016/0092-8674(87)90194-2. [DOI] [PubMed] [Google Scholar]
  5. Fromtling R. A., Abruzzo G. K., Giltinan D. M. Candida tropicalis infection in normal, diabetic, and neutropenic mice. J Clin Microbiol. 1987 Aug;25(8):1416–1420. doi: 10.1128/jcm.25.8.1416-1420.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hospenthal D. R., Rogers A. L., Beneke E. S. Effect of attachment of anticandidal antibody to the surfaces of liposomes encapsulating amphotericin B in the treatment of murine candidiasis. Antimicrob Agents Chemother. 1989 Jan;33(1):16–18. doi: 10.1128/aac.33.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kendall C., Ionescu-Matiu I., Dreesman G. R. Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods. 1983 Feb 11;56(3):329–339. doi: 10.1016/s0022-1759(83)80022-2. [DOI] [PubMed] [Google Scholar]
  8. Klebanoff S. J. Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin Hematol. 1975 Apr;12(2):117–142. [PubMed] [Google Scholar]
  9. Klebanoff S. J., Hamon C. B. Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc. 1972 Aug;12(2):170–196. [PubMed] [Google Scholar]
  10. Knowles D. M., 2nd, Sulivan T. J., 3rd, Parker C. W., Williams R. C., Jr In vitro antibody-enzyme conjugates with specific bactericidal activity. J Clin Invest. 1973 Jun;52(6):1443–1452. doi: 10.1172/JCI107318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Komshian S. V., Uwaydah A. K., Sobel J. D., Crane L. R. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis. 1989 May-Jun;11(3):379–390. doi: 10.1093/clinids/11.3.379. [DOI] [PubMed] [Google Scholar]
  12. Lambert J. M., Senter P. D., Yau-Young A., Blättler W. A., Goldmacher V. S. Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins. J Biol Chem. 1985 Oct 5;260(22):12035–12041. [PubMed] [Google Scholar]
  13. Langbakk B., Flatmark T. Demonstration and partial purification of lactoperoxidase from human colostrum. FEBS Lett. 1984 Sep 3;174(2):300–303. doi: 10.1016/0014-5793(84)81177-1. [DOI] [PubMed] [Google Scholar]
  14. Lanier L. L., Warner N. L. Paraformaldehyde fixation of hematopoietic cells for quantitative flow cytometry (FACS) analysis. J Immunol Methods. 1981;47(1):25–30. doi: 10.1016/0022-1759(81)90253-2. [DOI] [PubMed] [Google Scholar]
  15. Lehrer R. I. Antifungal effects of peroxidase systems. J Bacteriol. 1969 Aug;99(2):361–365. doi: 10.1128/jb.99.2.361-365.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Okuda K., Ishiwara K., Noguchi Y., Takahashi T., Tadokoro I. New type of antibody-enzyme conjugate which specifically kills Candida albicans. Infect Immun. 1980 Feb;27(2):690–692. doi: 10.1128/iai.27.2.690-692.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  18. Wingard J. R., Merz W. G., Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med. 1979 Oct;91(4):539–543. doi: 10.7326/0003-4819-91-4-539. [DOI] [PubMed] [Google Scholar]
  19. Wright C. D., Bowie J. U., Gray G. R., Nelson R. D. Candidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan. Infect Immun. 1983 Oct;42(1):76–80. doi: 10.1128/iai.42.1.76-80.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wright C. D., Nelson R. D. Candidacidal activity of myeloperoxidase: characterization of myeloperoxidase-yeast complex formation. Biochem Biophys Res Commun. 1988 Jul 29;154(2):809–817. doi: 10.1016/0006-291x(88)90212-4. [DOI] [PubMed] [Google Scholar]
  21. Yamada M., Mori M., Sugimura T. Purification and characterization of small molecular weight myeloperoxidase from human promyelocytic leukemia HL-60 cells. Biochemistry. 1981 Feb 17;20(4):766–771. doi: 10.1021/bi00507a018. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES